What does CUSIP 28106W103 represent in this 13F holders report?

CUSIP 28106W103 is the security identifier for EDIT - Editas Medicine, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EDIT - Editas Medicine, Inc. - Common Stock in Q4 2018?

187 institutional investors reported EDIT - Editas Medicine, Inc. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 82,773,190
Total 13F shares: 34,476,789
Share change: +1,239,001
Total reported value: $784,057,800
Put/Call ratio: 225%
Price per share: $22.75
Number of holders: 187
Value change: +$24,196,841
Number of buys: 77
Number of sells: 90

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 28106W103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	4.5%	3,729,579	$118,675,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	4.3%	3,589,141	$114,207,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	3.5%	2,923,738	$93,032,000	—	30 Sep 2018	13F
ARK Investment Management LLC	13F	Company	3.4%	2,793,854	$88,900,000	—	30 Sep 2018	13F
Capital World Investors	13F	Company	2.5%	2,032,000	$64,658,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	2.1%	1,731,967	$55,111,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	1.8%	1,523,278	$48,471,000	—	30 Sep 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.4%	1,158,841	$36,874,000	—	30 Sep 2018	13F
VIKING GLOBAL INVESTORS LP	13F	Company	1.1%	931,401	$29,637,000	—	30 Sep 2018	13F
CREDIT SUISSE AG/	13F	Company	0.95%	783,088	$24,918,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.93%	772,708	$24,588,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.87%	722,772	$22,998,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.66%	544,195	$17,316,000	—	30 Sep 2018	13F
Chevy Chase Trust Holdings, LLC	13F	Company	0.61%	502,139	$15,978,000	—	30 Sep 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.6%	495,900	$15,780,000	—	30 Sep 2018	13F
Global Thematic Partners, LLC	13F	Company	0.58%	481,568	$15,323,000	—	30 Sep 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.57%	471,241	$14,995,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	462,076	$14,704,000	—	30 Sep 2018	13F
Casdin Capital, LLC	13F	Company	0.56%	460,000	$14,637,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	453,820	$14,440,000	—	30 Sep 2018	13F
Valiant Capital Management, L.P.	13F	Company	0.46%	379,800	$12,085,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.36%	300,100	$9,549,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.33%	274,333	$8,729,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.29%	242,856	$7,728,000	—	30 Sep 2018	13F
JS Capital Management LLC	13F	Company	0.26%	218,935	$6,967,000	—	30 Sep 2018	13F
NORGES BANK	13F	Company	0.25%	202,874	$6,455,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.24%	198,851	$6,327,000	—	30 Sep 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.24%	198,493	$6,316,047	—	30 Sep 2018	13F
Wildcat Capital Management, LLC	13F	Company	0.22%	185,668	$5,908,000	—	30 Sep 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.2%	167,049	$5,315,000	—	30 Sep 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.19%	157,581	$5,014,000	—	30 Sep 2018	13F
Capital International Investors	13F	Company	0.18%	152,000	$4,837,000	—	30 Sep 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.18%	147,353	$4,689,000	—	30 Sep 2018	13F
Handelsbanken Fonder AB	13F	Company	0.16%	135,000	$4,296,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0.16%	130,187	$4,143,000	—	30 Sep 2018	13F
FIRST TRUST ADVISORS LP	13F	Company	0.15%	122,425	$3,896,000	—	30 Sep 2018	13F
CAPITAL ADVISORS INC/OK	13F	Company	0.15%	121,701	$3,873,000	—	30 Sep 2018	13F
Hudson Bay Capital Management LP	13F	Company	0.13%	110,000	$3,500,000	—	30 Sep 2018	13F
PDT Partners, LLC	13F	Company	0.12%	98,525	$3,135,000	—	30 Sep 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.12%	97,400	$3,099,000	—	30 Sep 2018	13F
Elmwood Wealth Management, Inc.	13F	Company	0.11%	94,067	$2,993,212	—	30 Sep 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.11%	87,200	$2,775,000	—	30 Sep 2018	13F
WS MANAGEMENT LLLP	13F	Company	0.1%	86,765	$2,761,000	—	30 Sep 2018	13F
Crestwood Advisors Group, LLC	13F	Company	0.1%	85,281	$2,714,000	—	30 Sep 2018	13F
Allianz Asset Management GmbH	13F	Company	0.1%	82,303	$2,619,000	—	30 Sep 2018	13F
FIDUCIARY TRUST CO	13F	Company	0.09%	77,079	$2,452,000	—	30 Sep 2018	13F
Tekla Capital Management LLC	13F	Company	0.09%	76,668	$2,440,000	—	30 Sep 2018	13F
Granahan Investment Management, LLC	13F	Company	0.09%	76,057	$2,420,000	—	30 Sep 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.09%	71,863	$2,287,000	—	30 Sep 2018	13F
NISA INVESTMENT ADVISORS, LLC	13F	Company	0.09%	71,310	$2,269,000	—	30 Sep 2018	13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2018

As of 31 Dec 2018, Editas Medicine, Inc. - Common Stock (EDIT) was held by 187 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,476,789 shares. The largest 10 holders included Vanguard Group Inc, BlackRock Inc., ARK Investment Management LLC, STATE STREET CORP, Capital World Investors, MORGAN STANLEY, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CREDIT SUISSE AG/, and Viking Global Investors LP. This page lists 187 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

192

Q4 2018 holders

187

Holder diff

-5

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.